Cargando…
Uptake of biosimilar drugs in Canada: analysis of provincial policies and usage data
Autores principales: | McClean, Alison R., Law, Michael R., Harrison, Mark, Bansback, Nick, Gomes, Tara, Tadrous, Mina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035299/ https://www.ncbi.nlm.nih.gov/pubmed/35440506 http://dx.doi.org/10.1503/cmaj.211478 |
Ejemplares similares
-
Adoption des médicaments biosimilaires au Canada : analyse des politiques provinciales et données sur leur utilisation
por: McClean, Alison R., et al.
Publicado: (2022) -
Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis
por: Gomes, Tara, et al.
Publicado: (2021) -
Patient perspectives on the British Columbia Biosimilars Initiative: a qualitative descriptive study
por: Chew, Caitlin, et al.
Publicado: (2021) -
Policies for biosimilar uptake in Europe: An overview
por: Moorkens, Evelien, et al.
Publicado: (2017) -
Antipsychotic initiation among adults with intellectual and developmental disabilities in Ontario: a population-based cohort study
por: Gomes, Tara, et al.
Publicado: (2019)